Brain Circulation · 2023 · 60 citations · 6 references
MedicineNeurologyPharmacotherapyCerebrovascular NeurosurgeryCerebrovascular SurgeryDrug MetabolismAcute Ischemic StrokeAcute Stroke CareAcute Stroke ManagementCerebrovascular DiseaseStrokeThrombolytic TherapyAcute Ischemic Stroke InterventionAcute Ischemic Stroke ManagementAcute Ischemic Stroke ThrombolysisAcute Ischemic Stroke TreatmentIndications For ThrombolysisIntravenous Tissue Plasminogen ActivatorThrombolysis In Ischemic Stroke
Stroke is one of the primary causes of morbidity and death worldwide. While intravenous (IV) thrombolysis with alteplase has been widely proven to be beneficial for acute ischemic stroke patients, it still has many limitations. Tenecteplase, a revised version of alteplase, is a potential alternative IV thrombolytic agent that has benefits over alteplase. The aim of this mini-review is to summarize the advancements in IV thrombolysis for severe ischemic stroke, specifically the development and transition from alteplase to tenecteplase.
6
A Randomized Trial of Tenecteplase versus Alteplase for Acute Ischemic Stroke
Mark Parsons, Neil J. Spratt, Andrew Bivard et al. · New England Journal of Medicine · 2012 · 675 citations
Medicine, Neurology, Pharmacotherapy +15
Bijoy K. Menon, Brian Buck, Nishita Singh et al. · The Lancet · 2022 · 450 citations
Medicine, Neurology, Pharmacotherapy +11
Christopher Elnan Kvistad, Halvor Næss, Bernt Harald Helleberg et al. · The Lancet Neurology · 2022 · 205 citations